Concert Pharmaceuticals, Inc. Announces Appointment Of James V. Cassella As Chief Development Officer
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has appointed James V. Cassella, Ph.D. as Chief Development Officer. In this newly created role, Dr. Cassella will lead Concert’s product development strategy and operations and will have responsibility for all preclinical, clinical and manufacturing activities.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.